74 related articles for article (PubMed ID: 38438346)
21. Comparative efficacy and safety of therapeutics for elderly glioblastoma patients: A Bayesian network analysis.
Zhao B; Wu J; Xia Y; Li H; Wang Y; Qu T; Xing H; Wang Y; Ma W
Pharmacol Res; 2022 Aug; 182():106316. PubMed ID: 35724820
[TBL] [Abstract][Full Text] [Related]
22. Association of plasma levetiracetam concentration, MGMT methylation and sex with survival of chemoradiotherapy-treated glioblastoma patients.
Cucchiara F; Luci G; Giannini N; Giorgi FS; Orlandi P; Banchi M; Di Paolo A; Pasqualetti F; Danesi R; Bocci G
Pharmacol Res; 2022 Jul; 181():106290. PubMed ID: 35680010
[TBL] [Abstract][Full Text] [Related]
23. The role of ROS in tumour development and progression.
Cheung EC; Vousden KH
Nat Rev Cancer; 2022 May; 22(5):280-297. PubMed ID: 35102280
[TBL] [Abstract][Full Text] [Related]
24. UALCAN: An update to the integrated cancer data analysis platform.
Chandrashekar DS; Karthikeyan SK; Korla PK; Patel H; Shovon AR; Athar M; Netto GJ; Qin ZS; Kumar S; Manne U; Creighton CJ; Varambally S
Neoplasia; 2022 Mar; 25():18-27. PubMed ID: 35078134
[TBL] [Abstract][Full Text] [Related]
25. ROS-regulated phosphorylation of ITPKB by CAMK2G drives cisplatin resistance in ovarian cancer.
Li J; Zheng C; Wang M; Umano AD; Dai Q; Zhang C; Huang H; Yang Q; Yang X; Lu J; Pan W; Li B; Yao S; Pan C
Oncogene; 2022 Feb; 41(8):1114-1128. PubMed ID: 35039634
[TBL] [Abstract][Full Text] [Related]
26. The role of NADPH oxidases in infectious and inflammatory diseases.
Taylor JP; Tse HM
Redox Biol; 2021 Dec; 48():102159. PubMed ID: 34627721
[TBL] [Abstract][Full Text] [Related]
27. Antioxidant responses related to temozolomide resistance in glioblastoma.
Campos-Sandoval JA; Gómez-García MC; Santos-Jiménez JL; Matés JM; Alonso FJ; Márquez J
Neurochem Int; 2021 Oct; 149():105136. PubMed ID: 34274381
[TBL] [Abstract][Full Text] [Related]
28. Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance.
Huang H; Zhang S; Li Y; Liu Z; Mi L; Cai Y; Wang X; Chen L; Ran H; Xiao D; Li F; Wu J; Li T; Han Q; Chen L; Pan X; Li H; Li T; He K; Li A; Zhang X; Zhou T; Xia Q; Man J
Nat Commun; 2021 Jun; 12(1):3720. PubMed ID: 34140524
[TBL] [Abstract][Full Text] [Related]
29. E3 ligase TRIM25 ubiquitinates RIP3 to inhibit TNF induced cell necrosis.
Mei P; Xie F; Pan J; Wang S; Gao W; Ge R; Gao B; Gao S; Chen X; Wang Y; Wu J; Ding C; Li J
Cell Death Differ; 2021 Oct; 28(10):2888-2899. PubMed ID: 33953350
[TBL] [Abstract][Full Text] [Related]
30. TRIM25 activates AKT/mTOR by inhibiting PTEN via K63-linked polyubiquitination in non-small cell lung cancer.
He YM; Zhou XM; Jiang SY; Zhang ZB; Cao BY; Liu JB; Zeng YY; Zhao J; Mao XL
Acta Pharmacol Sin; 2022 Mar; 43(3):681-691. PubMed ID: 33931764
[TBL] [Abstract][Full Text] [Related]
31. Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients.
Zhao Z; Zhang KN; Wang Q; Li G; Zeng F; Zhang Y; Wu F; Chai R; Wang Z; Zhang C; Zhang W; Bao Z; Jiang T
Genomics Proteomics Bioinformatics; 2021 Feb; 19(1):1-12. PubMed ID: 33662628
[TBL] [Abstract][Full Text] [Related]
32. The Parkinson's disease-associated gene ITPKB protects against α-synuclein aggregation by regulating ER-to-mitochondria calcium release.
Apicco DJ; Shlevkov E; Nezich CL; Tran DT; Guilmette E; Nicholatos JW; Bantle CM; Chen Y; Glajch KE; Abraham NA; Dang LT; Kaynor GC; Tsai EA; Nguyen KH; Groot J; Liu Y; Weihofen A; Hurt JA; Runz H; Hirst WD
Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33443159
[TBL] [Abstract][Full Text] [Related]
33. The deubiquitinase USP36 Regulates DNA replication stress and confers therapeutic resistance through PrimPol stabilization.
Yan Y; Xu Z; Huang J; Guo G; Gao M; Kim W; Zeng X; Kloeber JA; Zhu Q; Zhao F; Luo K; Lou Z
Nucleic Acids Res; 2020 Dec; 48(22):12711-12726. PubMed ID: 33237263
[TBL] [Abstract][Full Text] [Related]
34. DGKA Provides Platinum Resistance in Ovarian Cancer Through Activation of c-JUN-WEE1 Signaling.
Li J; Pan C; Boese AC; Kang J; Umano AD; Magliocca KR; Yang W; Zhang Y; Lonial S; Jin L; Kang S
Clin Cancer Res; 2020 Jul; 26(14):3843-3855. PubMed ID: 32341033
[TBL] [Abstract][Full Text] [Related]
35. ROS in cancer therapy: the bright side of the moon.
Perillo B; Di Donato M; Pezone A; Di Zazzo E; Giovannelli P; Galasso G; Castoria G; Migliaccio A
Exp Mol Med; 2020 Feb; 52(2):192-203. PubMed ID: 32060354
[TBL] [Abstract][Full Text] [Related]
36. TRIM25 Promotes TNF-α-Induced NF-κB Activation through Potentiating the K63-Linked Ubiquitination of TRAF2.
Liu Y; Liu K; Huang Y; Sun M; Tian Q; Zhang S; Qin Y
J Immunol; 2020 Mar; 204(6):1499-1507. PubMed ID: 32024699
[TBL] [Abstract][Full Text] [Related]
37. Polyphyllin VII Promotes Apoptosis and Autophagic Cell Death via ROS-Inhibited AKT Activity, and Sensitizes Glioma Cells to Temozolomide.
Pang D; Li C; Yang C; Zou Y; Feng B; Li L; Liu W; Geng Y; Luo Q; Chen Z; Huang C
Oxid Med Cell Longev; 2019; 2019():1805635. PubMed ID: 31814867
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of inositol kinase B controls acute and chronic graft-versus-host disease.
Thangavelu G; Du J; Paz KG; Loschi M; Zaiken MC; Flynn R; Taylor PA; Kirchmeier AK; Panoskaltsis-Mortari A; Luznik L; MacDonald KP; Hill GR; Maillard I; Munn DH; Serody JS; Murphy WJ; Miklos D; Cutler CS; Koreth J; Antin JH; Soiffer RJ; Ritz J; Dahlberg C; Miller AT; Blazar BR
Blood; 2020 Jan; 135(1):28-40. PubMed ID: 31697815
[TBL] [Abstract][Full Text] [Related]
39. Redox-Mediated Mechanism of Chemoresistance in Cancer Cells.
Kim EK; Jang M; Song MJ; Kim D; Kim Y; Jang HH
Antioxidants (Basel); 2019 Oct; 8(10):. PubMed ID: 31658599
[TBL] [Abstract][Full Text] [Related]
40. Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma.
Lo Dico A; Salvatore D; Martelli C; Ronchi D; Diceglie C; Lucignani G; Ottobrini L
Cells; 2019 Oct; 8(11):. PubMed ID: 31653091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
